SE412913B - Forfarande for framstellning av nya cefalosporiner - Google Patents

Forfarande for framstellning av nya cefalosporiner

Info

Publication number
SE412913B
SE412913B SE989272A SE989272A SE412913B SE 412913 B SE412913 B SE 412913B SE 989272 A SE989272 A SE 989272A SE 989272 A SE989272 A SE 989272A SE 412913 B SE412913 B SE 412913B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
cephalosporines
new
new cephalosporines
Prior art date
Application number
SE989272A
Other languages
English (en)
Inventor
T Ishiguro
T Fugono
H Nomura
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE412913B publication Critical patent/SE412913B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
SE989272A 1971-07-29 1972-07-28 Forfarande for framstellning av nya cefalosporiner SE412913B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5689571A JPS5442994B1 (sv) 1971-07-29 1971-07-29

Publications (1)

Publication Number Publication Date
SE412913B true SE412913B (sv) 1980-03-24

Family

ID=13040164

Family Applications (1)

Application Number Title Priority Date Filing Date
SE989272A SE412913B (sv) 1971-07-29 1972-07-28 Forfarande for framstellning av nya cefalosporiner

Country Status (14)

Country Link
JP (1) JPS5442994B1 (sv)
AT (1) AT318144B (sv)
AU (1) AU463668B2 (sv)
CA (1) CA1010443A (sv)
CH (1) CH592680A5 (sv)
DE (1) DE2236422C2 (sv)
DK (1) DK144177C (sv)
ES (1) ES405281A1 (sv)
FR (1) FR2147311B1 (sv)
GB (1) GB1368716A (sv)
HU (1) HU164342B (sv)
NL (1) NL177406C (sv)
NO (1) NO142913C (sv)
SE (1) SE412913B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51115493A (en) * 1975-03-18 1976-10-12 Smithkline Corp Novel cephalosporine compound

Also Published As

Publication number Publication date
FR2147311B1 (sv) 1976-03-05
NO142913B (no) 1980-08-04
GB1368716A (en) 1974-10-02
HU164342B (sv) 1974-01-28
JPS5442994B1 (sv) 1979-12-17
CH592680A5 (sv) 1977-10-31
AU463668B2 (en) 1975-07-31
DE2236422C2 (de) 1981-12-10
DK144177C (da) 1982-08-02
ES405281A1 (es) 1975-07-01
DE2236422A1 (de) 1973-02-22
NO142913C (no) 1980-11-12
FR2147311A1 (sv) 1973-03-09
AT318144B (de) 1974-09-25
AU4489272A (en) 1974-01-31
NL177406C (nl) 1985-09-16
DK144177B (da) 1982-01-04
CA1010443A (en) 1977-05-17
NL177406B (nl) 1985-04-16
NL7210382A (sv) 1973-01-31

Similar Documents

Publication Publication Date Title
FI56839B (fi) Foerfarande foer framstaellning av nya antibakteriella penicillinderivat
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE7809236L (sv) Forfarande for framstellning av estrar av penicilliner cefalosporiner
SE7509457L (sv) Forfarande for framstellning av nya pleuromutiliner
SE402772B (sv) Forfarande for framstellning av nya isotiocyanobensazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
SE401186B (sv) Forfarande for framstellning av nya penicilliner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE7613610L (sv) Forfarande for framstellning av penicilliner eller cefalosporiner
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE380815B (sv) Forfarande for framstellning av transparenta sampolyamider
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE387948B (sv) Forfarande for framstellning av tiofen